SWA
SLDB icon

SFMG Wealth Advisors’s Solid Biosciences SLDB Stock Holding History

SFMG Wealth Advisors’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$221K Hold
22,153
– – 0.01% 296
2026
Q1 		$160K Buy
+22,153
New +$142K 0.01% 305
2025
Q4 		– Sell
-25,031
Closed -$154K – 325
2025
Q3 		$154K Hold
25,031
– – 0.01% 292
2025
Q2 		$122K Hold
25,031
– – 0.01% 269
2025
Q1 		$92.6K Buy
+25,031
New +$107K 0.01% 269

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SFMG Wealth Advisors's SLDB Position: Q2 2026 in Review

SFMG Wealth Advisors held its Solid Biosciences (SLDB) position steady in Q2 2026 at 22,153 shares worth $221K. The position accounts for 0.01% of the portfolio, ranked #296.

SFMG Wealth Advisors first reported a position in SLDB in Q1 2025 and has held it in 5 quarters since. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • SFMG Wealth Advisors held 22,153 shares of Solid Biosciences worth $221K as of Q2 2026.
  • SFMG Wealth Advisors left its Solid Biosciences share count unchanged in Q2 2026.
  • Solid Biosciences made up 0.01% of SFMG Wealth Advisors's portfolio in Q2 2026, its #296 holding.
  • SFMG Wealth Advisors first reported a position in Solid Biosciences in Q1 2025 and has held it in 5 quarters since.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on SFMG Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.